Reciprocal modulation between TH17 and other helper T cell lineages

Journal of Cellular Physiology

Volumn 226, Issue 1, 2011, Pages 8-13

  Bi, Yujing ^a   Liu, Guangwei ^b   Yang, Ruifu ^a  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^b INSTITUTE OF ZOOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 17; ORPHAN NUCLEAR RECEPTOR; RETINOIC ACID RECEPTOR RELATED ORPHAN RECEPTOR GAMMAT; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ARTICLE; AUTOIMMUNE DISEASE; CELL DIFFERENTIATION; CELL LINEAGE; HELPER CELL; HUMAN; IMMUNOREGULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH17 CELL; TH2 CELL;

ANIMALS; CYTOKINES; HUMANS; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, HELPER-INDUCER; TH17 CELLS;

EID: 78049301672     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22331     Document Type: Article

References (73)

1. Annunziato F, Cosmi L, Santarlasci V, Maggi L, Liotta F, Mazzinghi B, Parente E, Fili L, Ferri S, Frosali F, Giudici F, Romagnani P, Parronchi P, Tonelli F, Maggi E, Romagnani S. 2007. Phenotypic and functional features of human Th17 cells. J Exp Med 204: 1849-1861.
2. Annunziato F, Cosmi L, Liotta F, Maggi E, Romagnani S. 2009. Type 17 T helper cells-origins, features and possible roles in rheumatic disease. Nat Rev Rheumatol 5: 325-331.
3. Awasthi A, Riol-Blanco L, Jager A, Korn T, Pot C, Galileos G, Bettelli E, Kuchroo VK, Oukka M. 2009. Cutting edge: IL-23 receptor gfp reporter mice reveal distinct populations of IL-17-producing cells. J Immunol 182: 5904-5908.
4. Bai H, Cheng J, Gao X, Joyee AG, Fan Y, Wang S, Jiao L, Yao Z, Yang X. 2009. IL-17/Th17 promotes type 1 T cell immunity against pulmonary intracellular bacterial infection through modulating dendritic cell function. J Immunol 183: 5886-5895.
5. Beriou G, Costantino CM, Ashley CW, Yang L, Kuchroo VK, Baecher-Allan C, Hafler DA. 2009. IL-17-producing human peripheral regulatory T cells retain suppressive function. Blood 113: 4240-4249.
6. Bettelli E, Pagany M, Weiner HL, Linington C, Sobel RA, Kuchroo VK. 2003. Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis. J Exp Med 197: 1073-1081.
7. Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, Weiner HL, Kuchroo VK. 2006a. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441: 235-238.
8. Bettelli E, Baeten D, Jager A, Sobel RA, Kuchroo VK. 2006b. Myelin oligodendrocyte glycoprotein-specific T and B cells cooperate to induce a Devic-like disease in mice. J Clin Invest 116: 2393-2402.
9. Bi Y, Liu G, Yang. R. 2007. Th17 cell induction and immune regulatory effects. J Cell Physiol 211: 273-278.
10. Blaschitz C, Raffatellu M. 2010. Th17 cytokines and the gut mucosal barrier. J Clin Immunol 30: 196-203.
11. Buonocore S, Ahern PP, Uhlig HH, Ivanov II, Littman DR, Maloy KJ, Powrie F. 2010. Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. Nature 464: 1371-1375.
12. Caruso R, Stolfi C, Sarra M, Rizzo A, Fantini MC, Pallone F, MacDonald TT, Monteleone G. 2009. Inhibition of monocyte-derived inflammatory cytokines by IL-25 occurs via p38 Map kinase-dependent induction of Socs-3. Blood 113: 3512-3519.
13. Cha HR, Chang SY, Chang JH, Kim JO, Yang JY, Kim CH, Kweon MN. 2010. Downregulation of Th17 cells in the small intestine by disruption of gut flora in the absence of retinoic acid. J Immunol 184: 6799-6806.
14. Chung Y, Chang SH, Martinez GJ, Yang XO, Nurieva R, Kang HS, Ma L, Watowich SS, Jetten AM, Tian Q, Dong. C. 2009. Critical regulation of early Th17 cell differentiation by interleukin-1 signaling. Immunity 30: 576-587.
15. Cui G, Qin X, Zhang Y, Gong Z, Ge B, Zang YQ. 2009. Berberine differentially modulates the activities of ERK, p38 MAPK, and JNK to suppress Th17 and Th1 T cell differentiation in type 1 diabetic mice. J Biol Chem 284: 28420-28429.
16. Dong C. 2008. TH17 cells in development: An updated view of their molecular identity and genetic programming. Nat Rev Immunol 8: 337-348.
17. Eddahri F, Denanglaire S, Bureau F, Spolski R, Leonard WJ, Leo O, Andris F. 2009. Interleukin-6/STAT3 signaling regulates the ability of naive T cells to acquire B-cell help capacities. Blood 113: 2426-2433.
18. Finotto S. 2008. T-cell regulation in asthmatic diseases. Chem Immunol Allergy 94: 83-92.
19. Hausding M, Sauer K, Maxeiner JH, Finotto S. 2008. Transgenic models in allergic responses. Curr Drug Targets 9: 503-510.
20. Hermann-Kleiter N, Baier G. 2010. NFAT pulls the strings during CD4+ T helper cell effector functions. Blood 115: 2989-2997.
21. Homs S, Mansour H, Desvaux D, Diet C, Hazan M, Buchler M, Lebranchu Y, Buob D, Badoual C, Matignon M, Audard V, Lang P, Grimbert P. 2009. Predominant Th1 and cytotoxic phenotype in biopsies from renal transplant recipients with transplant glomerulopathy. Am J Transplant 9: 1230-1236.
22. Horvat JC, Starkey MR, Kim RY, Beagley KW, Preston JA, Gibson PG, Foster PS, Hansbro PM. 2010. Chlamydial respiratory infection during allergen sensitization drives neutrophilic allergic airways disease. J Immunol 184: 4159-4169.
23. Horwitz DA, Zheng SG, Gray JD. 2008. Natural and TGF-beta-induced Foxp3(+)CD4(+) CD25(+) regulatory T cells are not mirror images of each other. Trends Immunol 29: 429-435.
24. Hruz P, Dann SM, Eckmann L. 2010. STAT3 and its activators in intestinal defense and mucosal homeostasis. Curr Opin Gastroenterol 26: 109-115.
25. Huber M, Brustle A, Reinhard K, Guralnik A, Walter G, Mahiny A, von Low E, Lohoff M. 2008. IRF4 is essential for IL-21-mediated induction, amplification, and stabilization of the Th17 phenotype. Proc Natl Acad Sci USA 105: 20846-20851.
26. Huber M, Heink S, Grothe H, Guralnik A, Reinhard K, Elflein K, Hunig T, Mittrucker HW, Brustle A, Kamradt T, Lohoff M. 2009. A Th17-like developmental process leads to CD8(+) Tc17 cells with reduced cytotoxic activity. Eur J Immunol 39: 1716-1725.
27. Jager A, Dardalhon V, Sobel RA, Bettelli E, Kuchroo VK. 2009. Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes. J Immunol 183: 7169-7177.
28. Klemann C, Raveney BJ, Oki S, Yamamura T. 2009. Retinoid signals and Th17-mediated pathology. Nihon Rinsho Meneki Gakkai Kaishi 32: 20-28.
29. Korn T, Reddy J, Gao W, Bettelli E, Awasthi A, Petersen TR, Backstrom BT, Sobel RA, Wucherpfennig KW, Strom TB, Oukka M, Kuchroo VK. 2007. Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. Nat Med 13: 423-431.
30. Korn T, Bettelli E, Oukka M, Kuchroo VK. 2009. IL-17 and Th17 cells. Annu Rev Immunol 27: 485-517.
31. Kriegel MA, Rathinam C, Flavell RA. 2009. E3 ubiquitin ligase GRAIL controls primary T cell activation and oral tolerance. Proc Natl Acad Sci USA 106: 16770-16775.
32. Kryczek I, Banerjee M, Cheng P, Vatan L, Szeliga W, Wei S, Huang E, Finlayson E, Simeone D, Welling TH, Chang A, Coukos G, Liu R, Zou W. 2009. Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments. Blood 114: 1141-1149.
33. Kwan BC, Tam LS, Lai KB, Lai FM, Li EK, Wang G, Chow KM, Li PK, Szeto CC. 2009. The gene expression of type 17 T-helper cell-related cytokines in the urinary sediment of patients with systemic lupus erythematosus. Rheumatology (Oxford) 48: 1491-1497.
34. Lee YK, Mukasa R, Hatton RD, Weaver CT. 2009. Developmental plasticity of Th17 and Treg cells. Curr Opin Immunol 21: 274-280.
35. Lin Y, Ritchea S, Logar A, Slight S, Messmer M, Rangel-Moreno J, Guglani L, Alcorn JF, Strawbridge H, Park SM, Onishi R, Nyugen N, Walter MJ, Pociask D, Randall TD, Gaffen SL, Iwakura Y, Kolls JK, Khader SA. 2009. Interleukin-17 is required for T helper 1 cell immunity and host resistance to the intracellular pathogen Francisella tularensis. Immunity 31: 799-810.
36. Locksley RM. 2009. Nine lives: Plasticity among T helper cell subsets. J Exp Med 206: 1643-1646.
37. Lu L, Wang J, Zhang F, Chai Y, Brand D, Wang X, Horwitz DA, Shi W, Zheng SG. 2010. Role of SMAD and non-SMAD signals in the development of Th17 and regulatory T cells. J Immunol 184: 4295-4306.
38. Mangini AJ, Lafyatis R, Van Seventer JM. 2007. Type I interferons inhibition of inflammatory T helper cell responses in systemic lupus erythematosus. Ann NY Acad Sci 1108: 11-23.
39. Martin B, Hirota K, Cua DJ, Stockinger B, Veldhoen M. 2009. Interleukin-17-producing gammadelta T cells selectively expand in response to pathogen products and environmental signals. Immunity 31: 321-330.
40. Matsushita S, Higashi T. 2008. Human Th17 cell clones and natural immune responses. Allergol Int 57: 135-140.
41. Mucida D, Park Y, Kim G, Turovskaya O, Scott I, Kronenberg M, Cheroutre H. 2007. Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 317: 256-260.
42. Mukherjee S, Schaller MA, Neupane R, Kunkel SL, Lukacs NW. 2009. Regulation of T cell activation by Notch ligand, DLL4, promotes IL-17 production and Rorc activation. J Immunol 182: 7381-7388.
43. Nath N, Khan M, Paintlia MK, Singh I, Hoda MN, Giri S. 2009. Metformin attenuated the autoimmune disease of the central nervous system in animal models of multiple sclerosis. J Immunol 182: 8005-8014.
44. Nistala K, Wedderburn LR. 2009. Th17 and regulatory T cells: Rebalancing pro- and anti-inflammatory forces in autoimmune arthritis. Rheumatology (Oxford) 48: 602-606.
45. O'Quinn DB, Palmer MT, Lee YK, Weaver CT. 2008. Emergence of the Th17 pathway and its role in host defense. Adv Immunol 99: 115-163.
46. Oukka M. 2007. Interplay between pathogenic Th17 and regulatory T cells. Ann Rheum Dis 66: iii87-iii90.
47. Ousman SS, Tomooka BH, van Noort JM, Wawrousek EF, O'Connor KC, Hafler DA, Sobel RA, Robinson WH, Steinman L. 2007. Protective and therapeutic role for alphaB-crystallin in autoimmune demyelination. Nature 448: 474-479.
48. Peron JP, de Oliveira AP, Rizzo LV. 2009. It takes guts for tolerance: The phenomenon of oral tolerance and the regulation of autoimmune response. Autoimmun Rev 9: 1-4.
49. Qin H, Wang L, Feng T, Elson CO, Niyongere SA, Lee SJ, Reynolds SL, Weaver CT, Roarty K, Serra R, Benveniste EN, Cong. Y. 2009. TGF-beta promotes Th17 cell development through inhibition of SOCS3. J Immunol 183: 97-105.
50. Ramgolam VS, Sha Y, Jin J, Zhang X, Markovic-Plese S. 2009. IFN-beta inhibits human Th17 cell differentiation. J Immunol 183: 5418-5427.
51. Ratajczak P, Janin A, Peffault de Latour, R, Leboeuf C, Desveaux A, Keyvanfar K, Robin M, Clave E, Douay C, Quinquenel A, Pichereau C, Bertheau P, Mary JY, Socie G. 2010. Th17/Treg ratio in human graft-versus-host-disease. Blood, Epub ahead of print.
52. Rolf J, Fairfax K, Turner M. 2010. Signaling pathways in T follicular helper cells. J Immunol 184: 6563-6568.
53. Romagnani S. 2008. Human Th17 cells. Arthritis Res Ther 10: 206.
54. Saito S, Nakashima A, Shima T, Ito M. 2010. Th1/Th2/Th17 and regulatory T-cell paradigm in pregnancy. Am J Reprod Immunol. 63: 601-610.
55. Schmidt-Weber CB. 2008. Th17 and treg cells innovate the TH1/TH2 concept and allergy research. Chem Immunol Allergy 94: 1-7.
56. Soroosh P, Doherty TA. 2009. Th9 and allergic disease. Immunology 127: 450-458.
57. Stockinger B, Veldhoen M. 2007. Differentiation and function of Th17 T cells. Curr Opin Immunol 19: 281-286.
58. Teng MW, Andrews DM, McLaughlin N, von Scheidt B, Ngiow SF, Moller A, Hill GR, Iwakura Y, Oft M, Smyth MJ. 2010. IL-23 suppresses innate immune response independently of IL-17A during carcinogenesis and metastasis. Proc Natl Acad Sci USA 107: 8328-8333.
59. Traves SL, Donnelly LE. 2008. Th17 cells in airway diseases. Curr Mol Med 8: 416-426.
60. van den Berg WB, Miossec P. 2009. IL-17 as a future therapeutic target for rheumatoid arthritis. Nat Rev Rheumatol 5: 549-553.
61. Voo KS, Wang YH, Santori FR, Boggiano C, Wang YH, Arima K, Bover L, Hanabuchi S, Khalili J, Marinova E, Zheng B, Littman DR, Liu. YJ. 2009. Identification of IL-17-producing FOXP3+ regulatory T cells in humans. Proc Natl Acad Sci USA 106: 4793-4798.
62. Weaver CT, Hatton RD. 2009. Interplay between the TH17 and TReg cell lineages: A (co-)evolutionary perspective. Nat Rev Immunol 9: 883-889.
63. Xiao S, Jin H, Korn T, Liu SM, Oukka M, Lim B, Kuchroo VK. 2008. Retinoic acid increases Foxp3+ regulatory T cells and inhibits development of Th17 cells by enhancing TGF-beta-driven Smad3 signaling and inhibiting IL-6 and IL-23 receptor expression. J Immunol 181: 2277-2284.
64. Yang XO, Nurieva R, Martinez GJ, Kang HS, Chung Y, Pappu BP, Shah B, Chang SH, Schluns KS, Watowich SS, Feng XH, Jetten AM, Dong C. 2008a. Molecular antagonism and plasticity of regulatory and inflammatory T cell programs. Immunity 29: 44-56.
65. Yang XO, Pappu BP, Nurieva R, Akimzhanov A, Kang HS, Chung Y, Ma L, Shah B, Panopoulos AD, Schluns KS, Watowich SS, Tian Q, Jetten AM, Dong. C. 2008b. T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma. Immunity 28: 29-39.
66. Yang K, Vega JL, Hadzipasic M, Schatzmann Peron JP, Zhu B, Carrier Y, Masli S, Rizzo LV, Weiner HL. 2009a. Deficiency of thrombospondin-1 reduces Th17 differentiation and attenuates experimental autoimmune encephalomyelitis. J Autoimmun 32: 94-103.
67. Yang J, Chu Y, Yang X, Gao D, Zhu L, Yang X, Wan L, Li M. 2009b. Th17 and natural Treg cell population dynamics in systemic lupus erythematosus. Arthritis Rheum 60: 1472-1483.
68. Yang Y, Weiner J, Liu Y, Smith AJ, Huss DJ, Winger R, Peng H, Cravens PD, Racke MK, Lovett-Racke AE. 2009c. T-bet is essential for encephalitogenicity of both Th1 and Th17 cells. J Exp Med 206: 1549-1564.
69. Yao C, Sakata D, Esaki Y, Li Y, Matsuoka T, Kuroiwa K, Sugimoto Y, Narumiya S. 2009. Prostaglandin E2-EP4 signaling promotes immune inflammation through Th1 cell differentiation and Th17 cell expansion. Nat Med 15: 633-640.
70. Yu D, Rao S, Tsai LM, Lee SK, He Y, Sutcliffe EL, Srivastava M, Linterman M, Zheng L, Simpson N, Ellyard JI, Parish IA, Ma CS, Li QJ, Parish CR, Mackay CR, Vinuesa CG. 2009. The transcriptional repressor Bcl-6 directs T follicular helper cell lineage commitment. Immunity 31: 457-468.
71. Zhou L, Chong MM, Littman DR. 2009. Plasticity of CD4+ T cell lineage differentiation. Immunity 30: 646-655.
72. Zhu J, Yamane H, Paul WE. 2010. Differentiation of effector CD4 T cell populations. Annu Rev Immunol 28: 445-489.
73. Ziegler SF, Buckner JH. 2009. FOXP3 and the regulation of Treg/Th17 differentiation. Microbes Infect 11: 594-598.